IRF4 and Miyoshi myopathy: In addition, an in vitro study has shown that CAPE and its analogues significantly reduced the level of interferon regulatory factor-4 (IRF-4) in MM cells, a crucial transcription factor controlling the defenestration of plasma cells (Murugesan et al., 2020).